Evaluation of antibody response in mice against avian influenza A (H5N1) strain neuraminidase expressed in yeast Pichia pastoris
- 20 March 2014
- journal article
- research article
- Published by Springer Nature in Journal of Biosciences
- Vol. 39 (3) , 443-451
Abstract
Avian influenza has raised many apprehension in the recent years because of its potential transmitability to humans. With the increasing emergence of drug-resistant avian influenza strains, development of potential vaccines are imperative to manage this disease. Two structural antigens, haemagglutinin and neuraminidase, have been the target candidates for the development of subunit vaccine against influenza. In an effort to develop a faster and economically beneficial vaccine, the neuraminidase gene of a highly pathogenic avian influenza isolate was cloned and expressed in the methylotrophic yeast Pichia pastoris. The recombinant neuraminidase (rNA) antigen was purified, and its bioactivity was analysed. The rNA was found to be functional, as determined by the neuraminidase assay. Four groups of mice were immunized with different concentrations of purified rNA antigen, which were adjuvanted with aluminium hydroxide. The immune response against rNA was analysed by enzyme-linked immunosorbent assay (ELISA) and neuraminidase inhibition assay. The mice groups immunized with 25 μg and 10 μg of antigen had a significant immune response against rNA. This method can be utilized for faster and cost-effective development of vaccines for a circulating and newer strain of avian influenza, and would aid in combating the disease in a pandemic situation, in which production time matters greatly.Keywords
This publication has 38 references indexed in Scilit:
- Yeast expressed classical swine fever E2 subunit vaccine candidate provides complete protection against lethal challenge infection and prevents horizontal virus transmissionVaccine, 2012
- A Cell Culture-Derived Influenza Vaccine Provides Consistent Protection Against Infection and Reduces the Duration and Severity of Disease in Infected IndividualsClinical Infectious Diseases, 2012
- Protection against Divergent Influenza H1N1 Virus by a Centralized Influenza HemagglutininPLOS ONE, 2011
- A Complete Analysis of HA and NA Genes of Influenza A VirusesPLOS ONE, 2010
- Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challengeProceedings of the National Academy of Sciences, 2010
- Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk DomainmBio, 2010
- NEW technologies for meeting the global demand for pandemic influenza vaccinesBiologicals, 2008
- Human Disease from Influenza A (H5N1), Thailand, 2004Emerging Infectious Diseases, 2005
- Expression of influenza neuraminidase in baculovirus-infected cellsVirus Research, 1992
- Studies on the role of myxovirus neuraminidase in virus-cell receptors interaction by means of direct determination of sialic acid split from cellsArchives of Virology, 1968